Shmuel Gov bought $8,956 of SSKN
COO at STRATA Skin Sciences, Inc.. 20,000 shares at an average of $0.45, traded Dec 1, 2023, filed Dec 5, 2023.
Score components
- +20RoleCOO
- 0Trade size$9k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +8Price context67% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001051514-23-000070, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 1, 2023 | POpen-market purchase SSKN Common Stock | +14,338 | $0.44 | $6,309 | 14,338 | Dec 5, 2023 |
| Dec 1, 2023 | POpen-market purchase SSKN Common Stock | +562 | $0.45 | $253 | 14,900 | Dec 5, 2023 |
| Dec 1, 2023 | POpen-market purchase SSKN Common Stock | +300 | $0.46 | $138 | 15,200 | Dec 5, 2023 |
| Dec 1, 2023 | POpen-market purchase SSKN Common Stock | +4,800 | $0.47 | $2,256 | 20,000 | Dec 5, 2023 |
Related signals
Other insiders at STRATA Skin Sciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | SSKNbuy STRATA Skin Sciences, Inc. | Samuel Rubinstein director | $7,028 5,000 shares | +133% | |
| 35Weak | SSKNsell STRATA Skin Sciences, Inc. | Samuel Rubinstein director | $19k 14,094 shares | -79% | |
| 15Weak | SSKNsell STRATA Skin Sciences, Inc. | Samuel Rubinstein director | $320 1,000 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.